𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Levetiracetam Prophylaxis in Pediatric Migraine—An Open-Label Study

✍ Scribed by Ann Pakalnis; Donna Kring; Lisa Meier

Book ID
109099893
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
58 KB
Volume
47
Category
Article
ISSN
0017-8748

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Levetiracetam in tardive dyskinesia: An
Levetiracetam in tardive dyskinesia: An open label study
✍ Spiros Konitsiotis; Sofia Pappa; Christos Mantas; Venos Mavreas 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 2 views

Levetiracetam (LEV), a novel antiepileptic drug, has demonstrated antidyskinetic effect in preclinical animal models of Parkinson's disease (PD) and in one open label study in PD patients with levodopa-induced dyskinesia. The acute antidyskinetic effects of LEV in patients with tardive dyskinesia we